Literature DB >> 12361491

Metabolic syndrome.

Margo A Denke1.   

Abstract

The metabolic syndrome is like an elephant, and any literary review of its importance is shamefully reduced to an examination of tusks, trunk, and tail. Evidence continues to mount that this diminutive approach is an incorrect management strategy for such a large problem. Diet and lifestyle are effective strategies, but they must effectively compete with behaviors that have instant gratification. Our society has turned its focus away from the long-term rewards of good sustainable behaviors and has instead focused on short-term rewards of unsustainable behaviors. To tame the behaviors that promote the metabolic syndrome, simple answers from diet and drug therapy will require support from society to be effective.

Entities:  

Mesh:

Year:  2002        PMID: 12361491     DOI: 10.1007/s11883-002-0048-9

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  24 in total

Review 1.  New drug targets for type 2 diabetes and the metabolic syndrome.

Authors:  D E Moller
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  The parental phenotype of diabetes, but not of essential hypertension, is linked to the development of metabolic syndrome in Mexican individuals.

Authors:  M Rodríguez-Morán; F Guerrero-Romero
Journal:  Acta Diabetol       Date:  2001       Impact factor: 4.280

3.  Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome.

Authors:  Sally D Poppitt; Geraldine F Keogh; Andrew M Prentice; Desmond E M Williams; Heidi M W Sonnemans; Esther E J Valk; Elizabeth Robinson; Nicholas J Wareham
Journal:  Am J Clin Nutr       Date:  2002-01       Impact factor: 7.045

4.  Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome.

Authors:  A Costa; I Igualá; J Bedini; L Quintó; I Conget
Journal:  Metabolism       Date:  2002-03       Impact factor: 8.694

Review 5.  Adipose tissue and the insulin resistance syndrome.

Authors:  K N Frayn
Journal:  Proc Nutr Soc       Date:  2001-08       Impact factor: 6.297

Review 6.  PPARS, insulin resistance and type 2 diabetes.

Authors:  F Kaplan; K Al-Majali; D J Betteridge
Journal:  J Cardiovasc Risk       Date:  2001-08

7.  Food patterns and components of the metabolic syndrome in men and women: a cross-sectional study within the Malmö Diet and Cancer cohort.

Authors:  E Wirfält; B Hedblad; B Gullberg; I Mattisson; C Andrén; U Rosander; L Janzon; G Berglund
Journal:  Am J Epidemiol       Date:  2001-12-15       Impact factor: 4.897

Review 8.  Visceral obesity and the metabolic syndrome: effects of weight loss.

Authors:  L Busetto
Journal:  Nutr Metab Cardiovasc Dis       Date:  2001-06       Impact factor: 4.222

9.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

Review 10.  Lipotoxic diseases.

Authors:  Roger H Unger
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.